No claims for monetary damages: Dr Reddy's on patent infringement

Claims sought injunctive relief to prohibit manufacturing, use, import, sale of palonosetron product

After receiving an unfavourable ruling in a US court, Dr Reddy's Laboratories (DRL) has said that there are no claims against the company for monetary damages in Helsinn Healthcare's patent infringement case over an anti-nauseant agent Aloxi.

As for 'quantum of claims', the claims only sought injunctive relief against the company to prohibit the manufacturing, use, import and sale of the company's palonosetron product prior to the expiration of the patents-in-suit. There is no monetary compensation or penalty damage owed to Helsinn because the proposed product palonosetron has not been marketed, DRL said in a statement.

Aloxi is the trade name of